High Circulating Follistatin-Like Protein 1 as a Biomarker of a Metabolically Unhealthy State

Endocrine Journal - Japan
doi 10.1507/endocrj.ej18-0352
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Endocrine Society

Related search

Circulating Apoptotic Endothelial Cell-Derived Microparticles Are Predicted Metabolically Unhealthy Obesity

Biomedical Research and Therapy
BiochemistryMedicineGeneticsMolecular Biology
2017English

Follistatin-Like 1 (FSTL1)

Science-Business eXchange
2013English

Circulating Melanoma Cells as a Predictive Biomarker

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2013English

Follistatin-Like Protein 1 Sustains Colon Cancer Cell Growth and Survival

Oncotarget
Oncology
2018English

510. Circulating microRNA as a Potential Biomarker of Ischemic Stroke

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Follistatin-Like Protein 1 Inhibits Lung Cancer Metastasis by Preventing Proteolytic Activation of Osteopontin

Cancer Research
Cancer ResearchOncology
2019English

A Genetic Polymorphism Affects the Risk and Prognosis of Renal Cell Carcinoma: Association With Follistatin-Like Protein 1 Expression

Scientific Reports
Multidisciplinary
2016English

Identification of PDL-1 as a Novel Biomarker of Sensitizer Exposure in Dendritic-Like Cells

Toxicology in Vitro
MedicineToxicology
2010English

Natural Killer Cell Activity and Interleukin-12 in Metabolically Healthy Versus Metabolically Unhealthy Overweight Individuals

Frontiers in Immunology
AllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy